Bioreactors are the potentially used device which is majorly used for biological reactions. These are used to grow numerous organisms such as yeast, bacteria, or animal cell under suitable environments. They maintain a sustainable environment for cell growth and product formation. Bioreactors are majorly used in the pharmaceutical and biotechnology industry for the production of vaccines, antibodies, or biological products. In addition, they are used in industrial processes for cultivating organisms under controlled conditions and for the production of pharmaceutical products for the treatment of various chronic diseases.
According to Data Bridge Market Research the Bioreactors Market accounted for USD 1,327.75 million in 2022, and expected to reach USD 2,439.43 million by 2030. The market is expected to grow with a CAGR of 7.9% in the forecast period of 2023 to 2030.
“Broad applications in the manufacturing of novel molecules”
The increasing adoption of advanced technologies aimed at simplifying complex manufacturing processes is expected to fuel the demand in the market. The segmental statistics are anticipated to be driven by the extensive utilization of bioreactors for the development and production of intricate molecules, including nucleic acids and proteins. These factors play a crucial role in driving the growth of the market.
What restraints the growth of the bioreactors market?
“Stringent rules and regulations”
There are various chemicals used for the manufacturing of bioreactors that are harmful to the environment. Governments globally are addressing this concern by implementing strict laws which the bioreactors industry needs to follow. Governments in several countries have undertaken several measures to deal with waste generation. The laws and regulations prohibit the production of bioreactors which is hindering the market’s growth.
Segmentation: Global Bioreactors Market
The bioreactors market is segmented on the basis of product type, cell, molecule, usage, scale, material, control type, suppliers, and end user
- On the basis of product type, the bioreactors market is segmented into single-use, reusable.
- On the basis of cell, the bioreactors market is segmented into mammalian cells, bacterial cells, and yeast cells.
- On the basis of molecule, the bioreactors market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy.
- On the basis of usage, the bioreactors market is segmented into lab-scale production, developmental, pre-clinical and clinical, commercial production, pilot-scale production, full-scale production.
- On the basis of scale, the bioreactors market is segmented into 5L-20L, 20L-200L, 200L-1500L, above 1500L.
- 根據材料，生物反應器市場分為玻璃、不銹鋼、一次性使用。
- 根據控制類型，生物反應器市場分為手動和自動化。
- 根據供應商，生物反應器市場分為 OEM、系統整合商和 EPC。
- 根據最終用戶，生物反應器市場細分為研發部門、研發機構、CRO、生物製藥公司、生物製藥製造商和CMOS。
區域洞察：亞太地區主導生物反應器市場
由於生命科學研究和開發的進步，北美佔據了市場主導地位。此外，在預測期內，投資的增加和生物製造設施的數量將推動該地區生物反應器市場的成長。
預計亞太地區將在2023年至2030年的預測期內以最高的成長率成長，原因是慢性病的增加以及對新型生物藥物的需求不斷增長，以及製藥公司數量的不斷增加。
要了解有關該研究的更多信息，請訪問：https://www.databridgemarketresearch.com/reports/global-bioreactors-market
生物反應器市場的最新發展
- 2022年，默克宣布收購龍沙的MAST平台，這是自動化無菌生物反應器取樣系統。這些平台幫助客戶優化生物加工過程中的數據。此次收購將有助於該公司擴大其市場佔有率。
- 2020年，丹納赫集團收購了通用電氣生命科學旗下的CYTIVA生物製藥業務。這項策略幫助該公司擴大了面向生物製藥客戶的產品供應並提高了市場滲透率。
生物反應器市場的主要參與者包括：
- 賽多利斯股份公司（德國）
- 賽默飛世爾科技公司（美國）
- 通用電氣（美國）
- Eppendorf AG（德國）
- 默克集團（德國）
- 頗爾公司（美國）
- ZETA（印度）
- 皮耶·蓋蘭（法國）
- PRaj Hipurity Systems Limited（印度）
- 生物工程股份公司（瑞士）
- Infors AG（瑞士）
- Solaris 生技有限公司（義大利）
- Bbi Biotech（德國）
- 上海百倫生物科技有限公司 (中國)
- PBS Biotech Inc.（美國）
- CerCell A/S（丹麥）
- GEA 集團股份公司（德國）
以上是報告中涉及的關鍵參與者，要了解更多生物反應器市場公司聯絡方式的詳盡列表，請訪問 https://www.databridgemarketresearch.com/contact
研究方法：全球生物反應器市場
資料收集和基準年分析是使用具有大樣本量的資料收集模組完成的。使用市場統計和相干模型來分析和估計市場數據。此外，市場佔有率分析和關鍵趨勢分析是市場報告中的主要成功因素。 DBMR 研究團隊使用的關鍵研究方法是資料三角測量，其中涉及資料探勘、資料變數對市場的影響分析以及初步（產業專家）驗證。除此之外，資料模型還包括供應商定位網格、市場時間軸分析、市場概覽和指南、公司定位網格、公司市場份額分析、測量標準、全球與區域以及供應商份額分析。如有進一步疑問，請要求分析師致電。
